Halo Biosciences
PrivateLast Round
Grant
May 15, 2024
Total Funding Raised
$1.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Halo Biosciences operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Grant round in May 2024.
Halo Biosciences is a clinical-stage biopharmaceutical company that develops disease-modifying therapies by targeting the extracellular matrix to treat inflammatory and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Halo Biosciences Comparables
Compare Halo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pliant Therapeutics | 73% | |
| Roivant Sciences | 72% | |
| Mediar Therapeutics | 71% |
For institutional investors. Book with your work email.
Halo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2024 | ||||
| Accelerator | Nov 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Halo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Grant |
| QB3 | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 30% MoM.
- Mar 5, 2026
Monthly visitors increased 200% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Halo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Halo Biosciences's valuation, stock price, and market status.
Is Halo Biosciences a public or private company?
Halo Biosciences is a private company.
What is the current stock price of Halo Biosciences?
Halo Biosciences is a private company, so its shares have no public market price. Caplight tracks Halo Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Halo Biosciences worth (valuation)?
Valuation information for Halo Biosciences is not publicly available.
Can I buy Halo Biosciences stock?
Halo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Halo Biosciences's last funding round?
Halo Biosciences's most recent funding round was Grant on May 15, 2024.
Who are the main investors in Halo Biosciences?
Key investors in Halo Biosciences include National Heart, Lung, and Blood Institute, QB3.
Will Halo Biosciences IPO soon?
No public IPO plans have been announced for Halo Biosciences.
How can I track Halo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Halo Biosciences's shares on secondary markets.